Pretreatment with mithramycin A for 24 h before irradiation significantly reduced clonogenic survival in vitro and delayed tumor regrowth in vivo, prolonging survival of EWS-FLI-positive tumor-bearing mice. The gene discussed is EWSR1; the disease is neoplasm.